{"name": "halazepam", "category": "drug", "content": "Halazepam  is a benzodiazepine derivative that was marketed under the brand names Paxipam in the United States,  Alapryl in Spain, and Pacinone in Portugal.   == Medical uses == Halazepam was used for the treatment of anxiety.   == Adverse effects == Adverse effects include drowsiness, confusion, dizziness, and sedation.  Gastrointestinal side effects have also been reported including dry mouth and nausea.   == Pharmacokinetics and pharmacodynamics == Pharmacokinetics and pharmacodynamics were listed in Current Psychotherapeutic Drugs published on June 15, 1998 as follows:   == Regulatory Information == Halazepam is classified as a schedule 4 controlled substance with a corresponding code 2762 by the Drug Enforcement Administration (DEA).   == Commercial production == Halazepam was invented by Schlesinger Walter in the U.S. It was marketed as an anti-anxiety agent in 1981. However, Halazepam is not commercially available in the United States because it was withdrawn by its manufacturer for poor sales.   == See also == Benzodiazepines Nordazepam Diazepam Chlordiazepoxide Quazepam, fletazepam, triflubazam \u2014 benzodiazepines with trifluoromethyl group attached   == References ==   == External links == Inchem - Halazepam"}